Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor–Positive and HER-2–Negative Breast Cancer with Neoadjuvant Chemotherapy

PURPOSE: This study investigated pathological complete response (pCR) according to androgen receptor (AR) in breast cancer patients undergoing neoadjuvant chemotherapy and estimated the relationship between AR expression and clinicopathological factors. MATERIALS AND METHODS: We identified 624 breas...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eun-Gyeong, Lee, Dong-Eun, Kim, Hyun Hee, Han, Jai Hong, Lee, Seeyoun, Kang, Han-Sung, Lee, Eun Sook, Chae, Heejung, Sim, Sung Hoon, Lee, Keun Seok, Kwon, Youngmee, Jung, So-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101776/
https://www.ncbi.nlm.nih.gov/pubmed/36097802
http://dx.doi.org/10.4143/crt.2022.834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101776/
https://www.ncbi.nlm.nih.gov/pubmed/36097802
http://dx.doi.org/10.4143/crt.2022.834

Ejemplares similares